Experienced, dynamic and dedicated leader with a demonstrated history of leading engagement with patient, professional and trade associations in the biotechnology industry.
Well versed in Federal healthcare policy issues including patient access, Medicare, Medicaid, PDUFA, 340B, value assessments, and intellectual property. Experienced in multiple disease areas, including lupus, psoriasis, arthritis, psychiatry, neurodegeneration, pain and osteoporosis. Strong, ethical and credible voice for patients with a background in both public policy and clinical development.
Vice President, External Affairs
Biotechnology Innovation Organization (BIO)